Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07356960
Eligibility Criteria:
Inclusion Criteria:
1. Patient is \> 18 years old;
2. Patient was treated in first-line with ponatinib monotherapy or in association with chemotherapy or immunotherapy;
3. Patient received ponatinib under the regulations of Law 648/96;
4. \- Patient is alive and have at least 18 months of retrospective observation available from the start of ponatinib treatment, OR
\- has died/lost to follow-up at any time after treatment initiation, regardless of the length of available follow-up;
5. Signed informed consent, if applicable.
Exclusion Criteria:
* None
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07356960
Study Brief:
Protocol Section:
NCT07356960